Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy?. MacLennan, J, Urwin, R., Obaro, S., Griffiths, D., Greenwood, B., & Maiden, M. C. The Lancet, 356(9235):1078, September, 2000.
Paper doi abstract bibtex Summary We found high levels of symptomless carriage of a hyperinvasive Neisseria meningitidis strain (electrophoretic type 37 [ET-37], serogroup W-135) during a vaccine trial in Gambian children in 1996. Serogroup C, ET-37 complex meningococci cause 30–40% of meningococcal disease in countries such as the UK, and have a point prevalence of 0·5–1·0%. The recent Haj-associated spread of serogroup W-135, ET-37 complex meningococci, which has been accompanied by numerous secondary cases, might be explained by the apparently raised carriage rates reported here.
@article{maclennan_carriage_2000,
title = {Carriage of serogroup {W}-135, {ET}-37 meningococci in {The} {Gambia}: implications for immunisation policy?},
volume = {356},
issn = {0140-6736},
shorttitle = {Carriage of serogroup {W}-135, {ET}-37 meningococci in {The} {Gambia}},
url = {http://www.sciencedirect.com/science/article/pii/S0140673600027343},
doi = {10.1016/S0140-6736(00)02734-3},
abstract = {Summary
We found high levels of symptomless carriage of a hyperinvasive Neisseria meningitidis strain (electrophoretic type 37 [ET-37], serogroup W-135) during a vaccine trial in Gambian children in 1996. Serogroup C, ET-37 complex meningococci cause 30–40\% of meningococcal disease in countries such as the UK, and have a point prevalence of 0·5–1·0\%. The recent Haj-associated spread of serogroup W-135, ET-37 complex meningococci, which has been accompanied by numerous secondary cases, might be explained by the apparently raised carriage rates reported here.},
number = {9235},
urldate = {2014-08-14},
journal = {The Lancet},
author = {MacLennan, J and Urwin, Rachel and Obaro, Steven and Griffiths, David and Greenwood, Brian and Maiden, Martin CJ},
month = sep,
year = {2000},
pages = {1078},
}
Downloads: 0
{"_id":"23ZhitqaM6fWzCh9c","bibbaseid":"maclennan-urwin-obaro-griffiths-greenwood-maiden-carriageofserogroupw135et37meningococciinthegambiaimplicationsforimmunisationpolicy-2000","author_short":["MacLennan, J","Urwin, R.","Obaro, S.","Griffiths, D.","Greenwood, B.","Maiden, M. C."],"bibdata":{"bibtype":"article","type":"article","title":"Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy?","volume":"356","issn":"0140-6736","shorttitle":"Carriage of serogroup W-135, ET-37 meningococci in The Gambia","url":"http://www.sciencedirect.com/science/article/pii/S0140673600027343","doi":"10.1016/S0140-6736(00)02734-3","abstract":"Summary We found high levels of symptomless carriage of a hyperinvasive Neisseria meningitidis strain (electrophoretic type 37 [ET-37], serogroup W-135) during a vaccine trial in Gambian children in 1996. Serogroup C, ET-37 complex meningococci cause 30–40% of meningococcal disease in countries such as the UK, and have a point prevalence of 0·5–1·0%. The recent Haj-associated spread of serogroup W-135, ET-37 complex meningococci, which has been accompanied by numerous secondary cases, might be explained by the apparently raised carriage rates reported here.","number":"9235","urldate":"2014-08-14","journal":"The Lancet","author":[{"propositions":[],"lastnames":["MacLennan"],"firstnames":["J"],"suffixes":[]},{"propositions":[],"lastnames":["Urwin"],"firstnames":["Rachel"],"suffixes":[]},{"propositions":[],"lastnames":["Obaro"],"firstnames":["Steven"],"suffixes":[]},{"propositions":[],"lastnames":["Griffiths"],"firstnames":["David"],"suffixes":[]},{"propositions":[],"lastnames":["Greenwood"],"firstnames":["Brian"],"suffixes":[]},{"propositions":[],"lastnames":["Maiden"],"firstnames":["Martin","CJ"],"suffixes":[]}],"month":"September","year":"2000","pages":"1078","bibtex":"@article{maclennan_carriage_2000,\n\ttitle = {Carriage of serogroup {W}-135, {ET}-37 meningococci in {The} {Gambia}: implications for immunisation policy?},\n\tvolume = {356},\n\tissn = {0140-6736},\n\tshorttitle = {Carriage of serogroup {W}-135, {ET}-37 meningococci in {The} {Gambia}},\n\turl = {http://www.sciencedirect.com/science/article/pii/S0140673600027343},\n\tdoi = {10.1016/S0140-6736(00)02734-3},\n\tabstract = {Summary\nWe found high levels of symptomless carriage of a hyperinvasive Neisseria meningitidis strain (electrophoretic type 37 [ET-37], serogroup W-135) during a vaccine trial in Gambian children in 1996. Serogroup C, ET-37 complex meningococci cause 30–40\\% of meningococcal disease in countries such as the UK, and have a point prevalence of 0·5–1·0\\%. The recent Haj-associated spread of serogroup W-135, ET-37 complex meningococci, which has been accompanied by numerous secondary cases, might be explained by the apparently raised carriage rates reported here.},\n\tnumber = {9235},\n\turldate = {2014-08-14},\n\tjournal = {The Lancet},\n\tauthor = {MacLennan, J and Urwin, Rachel and Obaro, Steven and Griffiths, David and Greenwood, Brian and Maiden, Martin CJ},\n\tmonth = sep,\n\tyear = {2000},\n\tpages = {1078},\n}\n\n","author_short":["MacLennan, J","Urwin, R.","Obaro, S.","Griffiths, D.","Greenwood, B.","Maiden, M. C."],"key":"maclennan_carriage_2000","id":"maclennan_carriage_2000","bibbaseid":"maclennan-urwin-obaro-griffiths-greenwood-maiden-carriageofserogroupw135et37meningococciinthegambiaimplicationsforimmunisationpolicy-2000","role":"author","urls":{"Paper":"http://www.sciencedirect.com/science/article/pii/S0140673600027343"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/robin.marlow","dataSources":["ix72eqAAMGCuupBaz"],"keywords":[],"search_terms":["carriage","serogroup","135","meningococci","gambia","implications","immunisation","policy","maclennan","urwin","obaro","griffiths","greenwood","maiden"],"title":"Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy?","year":2000}